Rostand K S, Baker J R, Caterson B, Christner J E
Arthritis Rheum. 1986 Jan;29(1):95-105. doi: 10.1002/art.1780290113.
Articular cartilage proteoglycans from an osteoarthritic mouse strain, STR/IN, were labeled in vivo with 35S-sulfate and characterized with respect to extractability, ability to aggregate, size of monomer and glycosaminoglycan chains, sulfation of glycosaminoglycans, relative amounts of chondroitin-4 sulfate and chondroitin-6 sulfate, and link proteins. The proportion of 35S-labeled proteoglycans extractable by 0.4M guanidine hydrochloride was the same in control and osteoarthritic animals. However, a greater proportion was extractable by 4M guanidine hydrochloride in the STR/IN animals as compared with the control mice. The ability of the 35S-proteoglycans to aggregate was comparable in controls and osteoarthritic mice, as judged by their exclusion on Sepharose CL-2B. Monomers from both controls and osteoarthritic animals eluted from Sepharose CL-2B with a KAV of 0.47. Glycosaminoglycans from control and osteoarthritic animals eluted from Sepharose CL-6B with a KAV of 0.63, and no differences in sulfation or chondroitin-4 sulfate content were found. Aggregates were immunoprecipitated with link protein-specific antiserum, and only link protein 2 was found in aggregates from control and osteoarthritic animals.
来自骨关节炎小鼠品系STR/IN的关节软骨蛋白聚糖在体内用35S-硫酸盐进行标记,并在可提取性、聚集能力、单体和糖胺聚糖链的大小、糖胺聚糖的硫酸化、硫酸软骨素-4和硫酸软骨素-6的相对含量以及连接蛋白方面进行了表征。在对照动物和骨关节炎动物中,0.4M盐酸胍可提取的35S标记蛋白聚糖的比例相同。然而,与对照小鼠相比,STR/IN动物中4M盐酸胍可提取的比例更高。通过它们在琼脂糖CL-2B上的排阻判断,对照小鼠和骨关节炎小鼠中35S-蛋白聚糖的聚集能力相当。对照动物和骨关节炎动物的单体从琼脂糖CL-2B上洗脱时的KAV为0.47。对照动物和骨关节炎动物的糖胺聚糖从琼脂糖CL-6B上洗脱时的KAV为0.63,且未发现硫酸化或硫酸软骨素-4含量有差异。用连接蛋白特异性抗血清对聚集体进行免疫沉淀,在对照动物和骨关节炎动物的聚集体中仅发现连接蛋白2。